You are viewing the site in preview mode
Skip to main content
|
Interaction or contraindication
|
Number of prescriptions
|
Percentage
|
|---|
|
NSAIDs-non-steroidal anti-inflammatory drugs
|
142
|
35%
|
|
Beta blockers or ACE/ARBs used as monotherapy in patients of African origin,
|
69
|
17%
|
|
Atenolol administered to diabetics
|
53
|
13%
|
|
Thiazide-Amiloride combination containing hydrochlorothiazide 50 mg per tablet
|
45
|
11%
|
|
Medicines from the same therapeutic class being administered together
|
31
|
8%
|
|
Potassium sparing agents and ACE/ARBs administered together
|
19
|
5%
|
|
Hydrochlorothiazide prescribed to diabetics
|
17
|
4%
|
|
Hydrochlorothiazide prescribed to patients with gout
|
13
|
3%
|
|
Beta blockers and ACE/ARBs used as dual therapy in patients of African origin.
|
11
|
3%
|
|
Atenolol prescribed to asthmatics
|
6
|
1%
|
|
Total
|
406
|
100%
|
